Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

3.4K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.4K
Protein Absorption01:12

Protein Absorption

818
Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
818
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

417
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
417
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

155
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
155
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

643
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
643
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

379
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNAs and predicted targets in the switch from monolayered to spheroids of cholangiocarcinoma cells.

Experimental and molecular pathology·2026
Same author

Urgent endoscopic submucosal dissection of an obstructing, bleeding giant duodenal "Brunneroma".

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy·2026
Same author

Sustainability in endoscopic medical congresses and courses: Position Statement from the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology and Endoscopy Nurses and Associates.

Endoscopy·2026
Same author

Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance.

United European gastroenterology journal·2026
Same author

The Saline-Immersion/Irrigation TEchnique for Endoscopic Submucosal Dissection: Moving Towards Augmented Visibility, Natural "Traction," Optimized Vessel Management, and Enhanced Patient Comfort.

Journal of gastroenterology and hepatology·2026
Same author

Acute Gastrointestinal Bleeding: An Update and a Practical Diagnostic Approach.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Dec 28, 2025

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

3.2K

Protein-losing enteropathy.

Luca Elli1,2, Matilde Topa1,2, Alessandro Rimondi1,2

  • 1Center for Prevention and Diagnosis of Coeliac Disease - Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Current Opinion in Gastroenterology
|February 20, 2020
PubMed
Summary
This summary is machine-generated.

This review provides a practical guide for diagnosing and treating protein-losing enteropathy. Innovations like enteroscopy aid in identifying the causes of protein loss, while nutritional support and underlying disease management are key.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.6K

Related Experiment Videos

Last Updated: Dec 28, 2025

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

3.2K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.6K

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Protein-losing enteropathy (PLE) is a significant clinical manifestation of various gastrointestinal and extra-intestinal diseases.
  • Current literature and guidelines for PLE are limited, necessitating practical clinical tools.

Purpose of the Study:

  • To offer clinicians a practical overview of diagnostic and therapeutic strategies for protein-losing enteropathy.
  • To provide a supportive tool for managing patients with PLE in daily practice.

Main Methods:

  • Review of existing literature on protein-losing enteropathy.
  • Emphasis on recent advancements in diagnostic enteroscopic techniques (video-capsule and device-assisted enteroscopy).
  • Discussion of therapeutic innovations, including nutritional supplementation and management of underlying conditions.

Main Results:

  • Enteroscopic techniques have significantly advanced the diagnostic approach to PLE by enabling direct visualization of the small bowel.
  • While a definitive diagnostic flowchart is lacking, enteroscopy aids in identifying the source of protein loss.
  • Nutritional support and targeted therapy for the underlying disease are crucial for effective patient management.

Conclusions:

  • Protein-losing enteropathy requires a comprehensive approach involving advanced diagnostics and tailored therapies.
  • Enteroscopy represents a key innovation in the diagnosis of PLE.
  • Effective management hinges on addressing the root cause and providing nutritional support.